Share this Post!

The Food and Drug Administration (FDA) is developing the draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, entitled, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs”” and its Amendments. The proposed issuance aims to rationalize the fee structure of the FDA to further strengthen the agency in the exercise of its mandate of regulating health products and establishments under its jurisdiction.

To further enhance the draft issuance, the FDA is hereby inviting our stakeholders to join the Virtual Consultation to be held on 27 October 2023, 9:00AM via MS Teams platform. One (1) participant per association shall be allowed in the virtual consultation.

The registration to the Virtual Consultation is accessible through this link:

Stakeholders of processed food products, ingredients and raw materials under the Center for Food Regulation Research

Stakeholders of drug products under the Center for Drug Regulation and Research

Stakeholders of medical device, health-related device and radiation facilities under the Center for Device Regulation, Radiation Health, and Research

Stakeholders of cosmetics, toys and childcare articles, household/urban hazardous substances, household/urban pesticides under the Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research

Limited slots are available, as such, registration is on a first-come, first-served basis.

Access to the virtual consultation shall be sent to the nominated participant through the registered email address.

Further, provided herewith is the copy of the draft Administrative Order for reference.

Kindly send your comments on the AO and Annexes to the link: